Angiopoietin-like protein 2 is a potential biomarker for gastric cancer

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 2653-2658

  Yoshinaga, Takuma ^a,b   Shigemitsu, Takamasa ^a   Nishimata, Hiroto ^b   Takei, Takayuki ^a   Yoshida, Masahiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Nanpuh Hospital   (Japan)

Author keywords

Angiopoietin like protein 2; Biomarker; Gastric cancer; HGC 27 cell line; MKN7 cell line; Serum

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN LIKE PROTEIN 2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; FOLLISTATIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; LEPTIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOPOIETIN; ANGPTL2 PROTEIN, HUMAN; VASCULOTROPIN A;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SERUM; STOMACH CANCER; ADULT; BLOOD; CANCER STAGING; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921417637     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3040     Document Type: Article

References (16)

1. Loei H, Tan HT, Lim TK, Lim KH, So JB, Yeoh KG and Chung MC: Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res 11: 1759-1172, 2012.
2. Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G, et al: Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol 30: 365, 2013.
3. Tan YK and Fielding JW: Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol 18: 821-829, 2006.
4. Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY and Zhu ZG: MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol 108: 89-92, 2013.
5. Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22: 2311-2316, 2002.
6. Lukaszewicz-Zając M, Mroczko B, Gryko M, Kędra B and Szmitkowski M: Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med 11: 89-96, 2011.
7. Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J and Imoto I: Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Res 68: 5067-5075, 2008.
8. Oike Y, Yasunaga K and Suda T: Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol 80: 21-28, 2004.
9. Sfiligoi C, de Luca A, Cascone I, Sorbello V, Fuso L, Ponzone R, Biglia N, Audero E, Arisio R, Bussolino F, et al: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103: 466-474, 2003.
10. Endo M, Nakano M, Kadomatsu T, Fukuhara S, Kuroda H, Mikami S, Hato T, Aoi J, Horiguchi H, Miyata K, et al: Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res 72: 1784-1794, 2012.
11. Jass JR and Sobin LH: Histological Typing of Intestinal Tumours. 2nd edition, Springer-Verlag, Berlin-Heidelberg-New York, 1989.
12. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, Miyashita K, Semba K, Nakamura E, Tsukano M, et al: Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 176: 2309-2319, 2010.
13. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M and Ferrara N: Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57: 4593-4599, 1997.
14. Wang Q, Diao X, Sun J and Chen Z: Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy. Urol Oncol 31: 312-317, 2013.
15. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, Urano T, Zhu HJ, Tsukano H, Tazume H, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188, 2009.
16. Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Hata J, Iwase M, Kitazono T, Oike Y and Kiyohara Y: Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 36: 98-100, 2013.